The further evaluation of these complex natural products or related analogues in vitro and in vivo could prove to be helpful for the development of eEF2K inhibiting anticancer agents, perhaps especially for pancreatic cancers. This evidence concerns the gene EEF2K and pancreatic neoplasm.